Skip to main content
Vivimed Labs Ltd. logo

Vivimed Labs Ltd. — Investor Relations & Filings

Ticker · VIVIMEDLAB ISIN · INE526G01021 LEI · 335800LYN9TN3F87WV86 BSE.NS Manufacturing
Filings indexed 865 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS VIVIMEDLAB

About Vivimed Labs Ltd.

http://www.vivimedlabs.com/

Vivimed Labs Ltd. specializes in the development and manufacture of active pharmaceutical ingredients (APIs), finished dosage formulations (FDF), and specialty chemicals. The company provides contract research and manufacturing services (CRAMS) and produces generic medicines across various therapeutic areas. Its specialty chemicals division focuses on niche products, including photochromic dyes for ophthalmic lenses, hair colorants, and anti-microbial agents for personal care and industrial use. Vivimed operates research and development centers and manufacturing facilities that adhere to international regulatory standards, catering to a global customer base in the healthcare and chemical sectors.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 92% confidence The document is a notice submitted to stock exchanges informing them of the postponement of a scheduled board meeting for Vivimed Labs Limited. It does not report any financial results, changes to board composition, or dividend details, nor is it an actual report or presentation. It is a standard regulatory announcement to the exchanges. The appropriate category for general regulatory announcements that do not fit more specific categories is Regulatory Filings (RNS).
2026-05-30 English
Board meeting Postponed
Regulatory Filings Classification · 65% confidence The document is a short notice to stock exchanges informing of the postponement of a board meeting originally scheduled to approve financial results. It does not contain financial statements or management changes, nor is it the financial report itself. It is a regulatory announcement that does not fit more specific categories, so it falls under the general regulatory filings category.
2026-05-30 English
Board Meeting — Board Meeting Intimation
Regulatory Filings Classification · 94% confidence The document is an XBRL instance under SEBI taxonomy for ‘Prior Intimation Of Board Meeting’ showing cancellation of a board meeting date. It is a regulatory compliance announcement rather than an actual financial report, management change, or AGM materials. Thus it best fits the general Regulatory Filings category (RNS).
2026-05-30 English
Board Meeting — Board meeting Rescheduled
Regulatory Filings Classification · 85% confidence The document is a formal notification to the stock exchanges that the Company’s Board Meeting (originally scheduled to approve financial results) has been postponed. It contains no financial data or results, no request for votes, no management changes, nor is it a call transcript or regulatory certification. It is a general regulatory announcement of an operational change. Therefore it falls under the fallback category of Regulatory Filings (RNS).
2026-05-30 English
The Board Meeting to be held on 28/05/2026 has been revised to 30/05/2026 The Board Meeting to be held on 28/05/2026 has been revised to 30/05/2026
Regulatory Filings Classification · 80% confidence The document is a brief stock exchange notice informing investors and regulators of the postponement of a scheduled board meeting (to consider and approve audited results). It contains no financial statements, not an earnings release, not a new report itself, and not a proxy or governance material. It is a general regulatory announcement, so it best fits the catch-all Regulatory Filings category (RNS).
2026-05-26 English
Updates
Regulatory Filings Classification · 92% confidence The document is titled 'Annual Secretarial Compliance Report' issued by the Company Secretary under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and submitted to BSE and NSE. It is a regulatory compliance certification rather than the full annual report or any financial statements. Under the CERTIFICATION RULE, such officer attestations or compliance certificates are classified as Regulatory Filings (RNS).
2026-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.